Prof. Michał KLEIBER
World awaits for temporary relaxation of intellectual property rights to vaccines against COVID-19
Contrary to the position of the pharmaceutical industry, the procedures of forced transfer of licences should not be treated as a violation of patent rights, as they are, to a certain extent, financially compensated, and, above all, are an expression of elementary ethics on the one hand, and a necessary safety measure for the health of the global population on the other.